GlassScriptPhysician profile
Manish B Marolia
NPI 1962581363
$1,033.34
in general payments reported to CMS, 2019-2025
9 companies · $17.91 in 2025
The $17.91 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $172 · 2021: $186 · 2022: $204 · 2023: $221 · 2024: $104 · 2025: $17.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $260.67 | 2020-2023 | Bexsero, Pediarix, Menveo |
| Sanofi Pasteur INC. | $208.30 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $207.62 | 2020-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Cranial Technologies, INC | $115.45 | 2019-2024 | Doc Band |
| Vifor Pharma, INC. | $113.08 | 2019 | |
| Supernus Pharmaceuticals, INC. | $51.43 | 2022 | |
| Boston Scientific Corporation | $45.20 | 2023 | Wavewriter Alpha Prime 16 |
| Exact Sciences Corporation | $17.34 | 2023 | Cologuard Collection Kit |
| Galderma Laboratories, L.P. | $14.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Marolia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.